Masahide Yamamoto, Maho Sato, Yasushi Onishi, Yoji Sasahara, Hideki Sano, Masayoshi Masuko, Hirohisa Nakamae, Ken-Ichi Matsuoka, Takahide Ara, Kana Washio, Makoto Onizuka, Kenichiro Watanabe, Yoshiyuki Takahashi, Tsuneaki Hirakawa, Miwako Nishio, Chizuko Sakashita, Tohru Kobayashi, Akihisa Sawada, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Hashii, Yoshiko Atsuta, Ayako Arai. Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan. Am J Hematol. 2022.06; 97 (6): 780-790. ( PubMed, DOI )

Tsuyoshi Nakagawa, Kumiko Hayashi, Ayumi Ogawa, Goshi Oda, Iichiro Onishi, Masahide Yamamoto, Mio Mori, Tomoyuki Fujioka, Toshiaki Ishikawa, Kentaro Okamoto, Hiroyuki Uetake. Bone Marrow Carcinomatosis in a Stage IV Breast Cancer Patient Treated by Letrozole as First-Line Endocrine Therapy. Case Rep Oncol. 2022.04; 15 (1): 436-441. ( PubMed, DOI )

Hirohisa Nakamae, Masahide Yamamoto, Emiko Sakaida, Yoshinobu Kanda, Ken Ohmine, Takaaki Ono, Itaru Matsumura, Maho Ishikawa, Makoto Aoki, Akio Maki, Hirohiko Shibayama. Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial. Int J Hematol. 2022.01; 115 (1): 33-42. ( PubMed, DOI )

Yuji Sekine, Kouhei Yamamoto, Morito Kurata, Ayaka Honda, Iichiroh Onishi, Yuko Kinowaki, Genji Kawade, Shiori Watabe, Serina Nomura, Sho Fukuda, Sachiko Ishibashi, Masumi Ikeda, Masahide Yamamoto, Masanobu Kitagawa. HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma. Pathology. 2021.09; (21): 435-439. ( PubMed, DOI )

Masayuki Nagasawa, Noriko Mitsuiki, Masakatsu Yanagimachi, Masahide Yamamoto, Tetsuya Fukuda, Osamu Miura, Ryutaro Oba, Akira Igarashi, Kinya Nagata, Tomohiro Morio. Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD. Int J Hematol. 2021.06; 113 (6): 910-920. ( PubMed, DOI )

Yuki Fukawa, Kei Sakamoto, Takuma Kugimoto, Yasuyuki Michi, Hiroyuki Harada, Masahide Yamamoto, Masanobu Kitagawa, Tohru Ikeda, Kouhei Yamamoto. Nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate. Pathol Int. 2021.03; 71 (3): 213-215. ( PubMed, DOI )

Yuta Izumi, Masashi Kanayama, Zhongchuzi Shen, Masayuki Kai, Shunsuke Kawamura, Megumi Akiyama, Masahide Yamamoto, Toshikage Nagao, Keigo Okada, Norihiko Kawamata, Shigeo Toyota, Toshiaki Ohteki. An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy. Front Immunol. 2021; 12 618081. ( PubMed, DOI )

Kuboki Mai, Umezawa Yoshihiro, Motomura Yotaro, Okada Keigo, Nogami Ayako, Nagao Toshikage, Miura Osamu, Yamamoto Masahide. Severe Motor Weakness Due to Disturbance in Peripheral Nerves Following Tisagenlecleucel Treatment IN VIVO. 2021; 35 (6): 3407-3411. ( PubMed, DOI )

Towako Taguchi, Morito Kurata, Iichiroh Onishi, Yuko Kinowako, Yunosuke Sato, Sayuri Shiono, Sachiko Ishibashi, Masumi Ikeda, Masahide Yamamoto, Masanobu Kitagawa, Kouhei Yamamoto. SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma. Lab Invest. 2020.10; ( PubMed, DOI )

Ichiro Yonese, Chizuko Sakashita, Ken-Ichi Imadome, Tohru Kobayashi, Masahide Yamamoto, Akihisa Sawada, Yoshinori Ito, Noriko Fukuhara, Asao Hirose, Yusuke Takeda, Masanori Makita, Tomoyuki Endo, Shun-Ichi Kimura, Masataka Ishimura, Osamu Miura, Shouichi Ohga, Hiroshi Kimura, Shigeyoshi Fujiwara, Ayako Arai. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020.07; 4 (13): 2918-2926. ( PubMed, DOI )

Shunya Matsumoto, Toshiki Kijima, Yoh Matsuoka, Masahide Yamamoto, Yasuhisa Fujii. A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab. Eur. J. Cancer. 2020.03; ( PubMed, DOI )

Koji Nishikawa, Kiminori Kimura, Yoshinobu Kanda, Masaya Sugiyama, Kazuhiko Kakihana, Noriko Doki, Kazuteru Ohashi, Sung Kwan Bae, Kazuhiro Takahashi, Yuko Ishihara, Ishikazu Mizuno, Yasushi Onishi, Masahiro Onozawa, Makoto Onizuka, Masahide Yamamoto, Tetsuya Ishikawa, Kazuaki Inoue, Shigeru Kusumoto, Satoshi Hashino, Hidetsugu Saito, Tatsuya Kanto, Hisashi Sakamaki, Masashi Mizokami. A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation. Bone Marrow Transplant.. 2020.02; ( PubMed, DOI )

Takashi Ikeda, Keita Mori, Koji Kawamura, Takehiko Mori, Shotaro Hagiwara, Yasunori Ueda, Kaoru Kahata, Naoyuki Uchida, Nobuhiro Tsukada, Satoshi Murakami, Masahide Yamamoto, Tsutomu Takahashi, Tatsuo Ichinohe, Makoto Onizuka, Yoshiko Atsuta, Yoshinobu Kanda, Shinichiro Okamoto, Kazutaka Sunami, Hiroyuki Takamatsu. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation. Hematol Oncol. 2019.10; ( PubMed, DOI )

Kota Yoshifuji, Yoshihiro Umezawa, Ayako Ichikawa, Ken Watanabe, Osamu Miura, Masahide Yamamoto. Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases. In Vivo. 2019.09; 33 (5): 1599-1604. ( PubMed, DOI )

Masahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, Toshikage Nagao, Shigeo Toyota, Osamu Miura. Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy. Anticancer Res.. 2019.09; 39 (9): 5115-5122. ( PubMed, DOI )

Kouhei Yamamoto, Shinya Abe, Ayaka Honda, Jun Hashimoto, Yuuki Aizawa, Sachiko Ishibashi, Taro Takemura, Nobutaka Hanagata, Masahide Yamamoto, Osamu Miura, Morito Kurata, Masanobu Kitagawa. Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma. Lab. Invest.. 2019.09; ( PubMed, DOI )

Keisuke Tanaka, Shigeo Toyota, Megumi Akiyama, Naoki Wakimoto, Yuichi Nakamura, Yuho Najima, Noriko Doki, Kazuhiko Kakihana, Aiko Igarashi, Takeshi Kobayashi, Kazuteru Ohashi, Daisuke Kudo, Atsushi Shinagawa, Hina Takano, Takayuki Fujio, Yasushi Okoshi, Mitsuo Hori, Takashi Kumagai, Tatsuya Saito, Junichi Mukae, Koh Yamamoto, Ikuyo Tsutsumi, Takuya Komeno, Chikashi Yoshida, Masahide Yamamoto, Hiroshi Kojima, . Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial. Acta Haematol.. 2019.02; 141 (2): 111-118. ( PubMed, DOI )

Junichi Tsuchiya, Masahide Yamamoto, Hyeyeol Bae, Takumi Oshima, Tomohiro Yoneyama, Osamu Miura, Ukihide Tateishi. Tumor Identification of Less Aggressive or Indolent Lymphoma With Whole-Body 11C-Acetate PET/CT. Clin Nucl Med. 2019.01; ( PubMed, DOI )

Makoto Nakagawa, Shuhei Fujita, Takuo Katsumoto, Kazutsune Yamagata, Yoko Ogawara, Ayuna Hattori, Yuki Kagiyama, Daisuke Honma, Kazushi Araki, Tatsuya Inoue, Ayako Kato, Koichiro Inaki, Chisa Wada, Yoshimasa Ono, Masahide Yamamoto, Osamu Miura, Yasuharu Nakashima, Issay Kitabayashi. Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma. Cancer Sci.. 2019.01; 110 (1): 194-208. ( PubMed, DOI )

Yuko Kinowaki, Morito Kurata, Sachiko Ishibashi, Masumi Ikeda, Anna Tatsuzawa, Masahide Yamamoto, Osamu Miura, Masanobu Kitagawa, Kouhei Yamamoto. Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma. Lab. Invest.. 2018.02; ( PubMed, DOI )

Masahide Yamamoto, Sayaka Suzuki, Jun-Ichi Mukae, Keisuke Tanaka, Ken Watanabe, Gaku Oshikawa, Tetsuya Fukuda, Naomi Murakami, Osamu Miura. Atypical chronic myeloid leukemia with isochromosome (X)(p10): A case report. Oncol Lett. 2017.09; 14 (3): 3717-3721. ( PubMed, DOI )

Keisuke Tanaka, Gaku Oshikawa, Hiroki Akiyama, Shinya Ishida, Toshikage Nagao, Masahide Yamamoto, Osamu Miura. Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report. Oncol Lett. 2017.07; 14 (1): 97-102. ( PubMed, DOI )

Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, Reina Watanabe, Yutaka Shimazu, Yasufumi Masaki, Saburo Tsunoda, Chizuko Hashimoto, Kayoko Murayama, Takahiro Yano, Rumiko Okamoto, Ako Kikuchi, Kazuo Tamura, Kazuya Sato, Kazutaka Sunami, Hirohiko Shibayama, Rishu Takimoto, Rika Ohshima, Hiromichi Takahashi, Yukiyoshi Moriuchi, Tomohiro Kinoshita, Masahide Yamamoto, Ayumi Numata, Hideaki Nakajima, Ikuo Miura, Kengo Takeuchi. The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis. Leuk. Lymphoma. 2017.06; 1-8. ( PubMed, DOI )

Masahide Yamamoto, Ken Watanabe, Tetsuya Fukuda, Osamu Miura. Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study. Anticancer Res.. 2017.05; 37 (5): 2655-2662. ( PubMed, DOI )

Koichi Miyamura, Toshihiro Miyamoto, Mitsune Tanimoto, Kazuhito Yamamoto, Shinya Kimura, Tatsuya Kawaguchi, Itaru Matsumura, Tomoko Hata, Hisashi Tsurumi, Shigeki Saito, Masayuki Hino, Seiji Tadokoro, Kuniaki Meguro, Hideo Hyodo, Masahide Yamamoto, Kohmei Kubo, Junichi Tsukada, Midori Kondo, Makoto Aoki, Hikaru Okada, Masamitsu Yanada, Kazuma Ohyashiki, Masafumi Taniwaki. Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy. Leuk. Res.. 2016.12; 51 11-18. ( PubMed, DOI )

Hiroki Akiyama, Hiroshi Takase, Fumito Kubo, Tohru Miki, Masahide Yamamoto, Makoto Tomita, Manabu Mochizuki, Osamu Miura, Ayako Arai. High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma. Cancer Science. 2016.10; 107 (10): 1458-1464. ( PubMed, DOI )

Masahide Yamamoto, Kazuteru Ohashi, Kazuhiko Kakihana, Yuichi Nakamura, Takuya Komeno, Hiroshi Kojima, Satoshi Morita, Hisashi Sakamaki. A multicenter clinical study to determine the feasible initial dose of lenalidomide for maintenance therapy in patients with multiple myeloma following autologous peripheral blood stem-cell transplantation. Mol Clin Oncol. 2016.06; 4 (6): 965-970. ( PubMed, DOI )

Shunichiro Yasuda, Masahide Yamamoto, Tetsuya Fukuda, Yasufumi Ohtsuka, Osamu Miura. Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab. Intern. Med.. 2016.05; 55 (9): 1171-1175. ( PubMed, DOI )

Arai A, Sakashita C, Hirose C, Imadome K, Yamamoto M, Jinta M, Fujiwara S, Tomita M, Shimizu N, Morio T, and Miura O.. Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers Bone Marrow Transplantation. 2016;

Emi Uchida, Ken Watanabe, Reina Arai, Masahide Yamamoto, Masayoshi Souri, Tsukasa Osaki, Akitada Ichinose, Osamu Miura, Takatoshi Koyama. Autoimmune Hemorrhaphilia Resulting from Autoantiboy against the A Subunit of Factor XIII. Internal Medicine. 2015.09; 54 (18): 2383-2387.

Masahide Yamamoto, Keigo Okada, Hiroki Akiyama, Tetsuya Kurosu, Osamu Miura. Evaluation of the efficacy of maintenance therapy for low-to-intermediate-risk acute promyelocytic leukemia in molecular remission: A retrospective single-institution study. Mol Clin Oncol. 2015.03; 3 (2): 449-453. ( PubMed, DOI )

Hiroki Akiyama, Masahide Yamamoto, Chizuko Sakashita, Yoshihiro Umezawa, Tetsuya Kurosu, Naomi Murakami, Osamu Miura. Therapy-related Leukemia with Inv(16)(p13.1q22) and Type D CBFB/MYH11 Developing after Exposure to Irinotecan-containing Chemoradiotherapy. Intern. Med.. 2015; 54 (6): 651-655. ( PubMed, DOI )

Toshikage Nagao, Tetsuya Kurosu, Yoshihiro Umezawa, Ayako Nogami, Gaku Oshikawa, Shuji Tohda, Masahide Yamamoto, Osamu Miura. Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera. PLoS ONE. 2014; 9 (1): e84746. ( PubMed, DOI )

Naoto Takahashi, Taiichi Kyo, Yasuhiro Maeda, Takashi Sugihara, Kensuke Usuki, Tatsuya Kawaguchi, Noriko Usui, Shinichiro Okamoto, Yokiko Ohe, Shigeki Ohtake, Kunio Kitamura, Masahide Yamamoto, Hirofumi Teshima, Toshiko Motoji, Toshiharu Tamaki, Kenichi Sawada, Kazuma Ohyashiki. Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia. Haematologica. 2012.06; 97 (6): 903-906. ( PubMed, DOI )

Naoto Tomita, Masahiro Yokoyama, Wataru Yamamoto, Reina Watanabe, Yutaka Shimazu, Yasufumi Masaki, Saburo Tsunoda, Chizuko Hashimoto, Kayoko Murayama, Takahiro Yano, Rumiko Okamoto, Ako Kikuchi, Kazuo Tamura, Kazuya Sato, Kazutaka Sunami, Hirohiko Shibayama, Rishu Takimoto, Rika Ohshima, Yoshihiro Hatta, Yukiyoshi Moriuchi, Tomohiro Kinoshita, Masahide Yamamoto, Ayumi Numata, Yoshiaki Ishigatsubo, Kengo Takeuchi. Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Sci.. 2012.02; 103 (2): 245-251. ( PubMed, DOI )

Masahide Yamamoto, Kazuteru Ohashi, Yuka Hirashima, Takeshi Kobayashi, Kazuhiko Kakihana, Hideki Akiyama, Hisashi Sakamaki. Poor outcome of myeloablative conditioned allogeneic bone marrow transplantation for myelofibrosis. Intern. Med.. 2012; 51 (10): 1183-1186. ( PubMed )

Yamamoto M, Kakihana K, Ohashi K, Yamaguchi T, Tadokoro K, Akiyama H, Sakamaki H. Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR. Int J Hematol. 2009.05; 89 (4): 482-488. ( PubMed, DOI )

Tetsuya Kurosu, Kana Tsuji, Manabu Ohki, Tohru Miki, Masahide Yamamoto, Kazuhiko Kakihana, Takatoshi Koyama, Shuichi Taniguchi, Osamu Miura. A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25). Int. J. Hematol.. 2008.09; 88 (2): 192-196. ( PubMed, DOI )

Kazuhiko Kakihana, Masahide Yamamoto, Mitsuko Iiyama, Osamu Miura. Calmodulin physically interacts with the erythropoietin receptor and enhances Jak2-mediated signaling. Biochem. Biophys. Res. Commun.. 2005.09; 335 (2): 424-431. ( PubMed, DOI )

Yamamoto M, Kakihana K, Kurosu T, Murakami N, Miura O. Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia. Cancer Genet Cytogenet. 2005.03; 157 (2): 104-108. ( PubMed, DOI )

Yamamoto M, Kurosu T, Kakihana K, Mizuchi D, Miura O. The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase. Biochem Biophys Res Commun. 2004.07; 319 (4): 1272-1275. ( PubMed, DOI )

Koi S, Nogami A, Fujiwara H, Bando K, Saito M, Osada Y, Tanaka K, Sakashita C, Yoshifuji K, Okada K, Umezawa Y, Nagao T, Yamamoto M, Mori T. [Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2023; 64 (11): 1426-1430. ( PubMed, DOI )

Moyu Kimura, Yu Nishiyama, Hiroki Ueda, Akiko Kitajo, Tomoyuki Arimatsu, Mai Kuboki, Atsushi Takahata, Makiko Saito, Chizuko Sakashita, Keigo Okada, Yoshihiro Umezawa, Toshikage Nagao, Masahide Yamamoto, Shuji Tohda, Minoru Tanabe, Takehiko Mori, Ayako Nogami. [Perioperative management of laparoscopic cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab treatment]. Rinsho Ketsueki. 2022; 63 (4): 260-264. ( PubMed, DOI )

野上　彩子、山本　正英、山本　浩平、伊藤　雅文、梅澤　佳央、東田　修二、三浦　修 、福田　哲也. 汎血球減少の長期経過後に明らかとなった辺縁帯リンパ腫様の骨髄原発リンパ腫 臨床血液. 2020; 61 (10): 1469-1475. ( PubMed, DOI )

山下 知子, 梅澤　佳央, 渡邉　健, 福田　哲也, 川又　紀彦, 三浦　修, 山本　正英 . 中枢神経リンパ腫に対するブスルファンを含む前処置を用いた自家造血幹細胞移植の検討 日本造血細胞移植学会誌. 2018.10; 7 (4): 145-151. ( DOI )

秋山　めぐみ,吉藤　康太,福田　哲也,東田　修二,三木　徹,三浦　修,山本　正英. 自己免疫性溶血性貧血に対するprednisolone治療中に発症した皮膚症状を伴わない劇症型内臓播種性VZV感染症 臨床血液. 2016.04; 57 (4): 467-471. ( PubMed, DOI )

内田　慧美, 渡邉　健, 押川　学, 坂下　千瑞子, 黒須　哲也, 福田　哲也, 新井　文子, 村上　直巳, 三浦　修, 山本　正英. MLL-AF9遺伝子転座を伴う難治性の乳房原発骨髄肉腫 臨床血液. 2016.01; 57 (1):

Masahide Yamamoto, Hanae Kumekawa, Koji Sasaki, Yutaka Murata, Manabu Ohki, Tetsuya Kurosu, Tetsuya Fukuda, Ayako Arai, Naomi Murakami, Osamu Miura. [Marked reactive plasmacytosis accompanied by drug eruption in a patient with aplastic anemia]. Rinsho Ketsueki. 2012.05; 53 (5): 526-530. ( PubMed )

Takayuki Suzuki, Ayako Arai, Takatoshi Koyama, Gaku Oshikawa, Masahide Yamamoto, Daisuke Mizuchi, Tetsuya Kurosu, Shuji Tohda, Naomi Murakami, Tohru Miki, Osamu Miura. [Ischemic colitis following the treatment of acute hemorrhage in a patient with acquired hemophilia A]. Rinsho Ketsueki. 2006.04; 47 (4): 310-314. ( PubMed )

Koh Yamamoto, Minako Yoshida, Masahide Yamamoto, Manabu Ohki, Tohru Miki, Takao Horiuchi, Masayuki Kurosaki, Mamoru Watanabe, Osamu Miura. [An abdominal follicular dendritic cell tumor in Castleman's disease]. Rinsho Ketsueki. 2004.09; 45 (9): 1033-1038. ( PubMed )

池田朱里、堤大樹、渡邉健、青山慧、齋藤達也、長尾俊景、坂下千瑞子、山本正英、福田哲也、東田修二、新井文子、川又紀彦、三浦修.. 二次性骨髄線維症による門脈圧亢進症性消化管出血に対してルキソリチニブが著効した一例. 日本血液学会関東甲信越地方会 2018.03.03 東京

Tomoko Yamashita, Hiroki Tsutsumi, Kota Yoshifuji, Tatsuya Saito, Yoshihiro Umezawa, Ayako Nogami, Ken Watanabe, Toshikage Nagao, Chizduko Sakashita, Masahide Yamamoto, Ayako Arai, Norihiko Kawamata, Osamu Miura, Tetsuya Fukuda. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with 11q Deletion. 第79回日本血液学会学術集会 2017.10.22

Ryoto Yoshimoto, Ken Watanabe, Emi Uchida, Shihoko Suwa, Shuji Tohda, Masahiko Hatano, Miura Osamu, Tetsuya Fukuda. IVNSIABP/Nd1 is highly expressed in refractory lymphoma as a novel therapeutic target molecule. The 79th Annual Meeting of the Japanese Society of Hematology 2017.10.20

渡邉健　他. Short chemotherapy prior to 90Y-ibritumomab tiuxetan for relapsed FL in a single institution.. 第77回日本血液学会学術集会 2015.10.18 石川県金沢市

Emi Uchida, Shunichirou Yasuda, Ken Watanabe, Gaku Oshikawa, Masahide Yamamoto, Tetsuya Kurosu, Ayako Arai, Osamu Miura, Tetsuya Fukuda. A retrospective analysis of CLL treated with the FCR regimen.. 第77回日本血液学会学術集会 2015.10

Kazuhito Yamamoto, Koich Miyamura, Toshihiro Miyamoto, Mitsune Tanimoto, Masafumi Taniwaki, Shinya Kimura, Kazuma Ohyashiki, Tatsuya Kawaguchi, Itaru Matshumura, Tomoko Hata, Hisashi Tsurumi, Shigeki Saito, Masayuki Hino, Seiji Tadokoro, Kuniaki Meguro, Hideo Hyodo, Masahide Yamamoto, Kohmei Kubo, Junichi Tsukada, Midori Kondo, Taro Amagasaki, Eiji Kawahara, Masamitsu Yanada. SENSOR INTERIM DATA WITH MUTATION ANALYSIS: SWITCHING TO NILOTINIB AFTER MOLECULAR SUBOPTIMAL RESPONSE TO IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE. 19th Congress of EHA 2014.06 Milan, Italy

野上　彩子、青山　慧、北浦　萌、山本　正英、東田　修二. CAR-T細胞療法後の遷延性血球減少症における免疫学的機構の解明. 第70回日本臨床検査医学会学術集会 2023.11.16 長崎

小川槙子,田中圭祐,吉藤康太,梅澤佳央,野上彩子,坂下千瑞子,長尾俊景,山本正英,森毅彦. チロシンキナーゼ阻害薬のみで長期に分子遺伝学的奏功を維持している急性期で発症した慢性骨髄性白血病. 日本血液学会関東甲信越地方会 2023.07.15 山梨

田中　圭祐、金井　光、桑原　宏哉、吉藤　康太、岡田　啓五、梅澤　佳央、野上　彩子、長尾　俊景、坂下　千瑞子、森　毅彦 、山本　正英. Fingolimod内服中に発生したびまん性大細胞型B細胞リンパ腫. 第63回　日本リンパ網内系学会学術集会 2023.06.24 大宮

中枢神経リンパ腫に対するブスルファンを含む前処置を用いた自家移植の検討. 2023.02.11

初澤　紘生, 田中　圭祐, 八木　真理絵, 大内　史彦, 金井　光, 千葉　桃子, 原田　拓実, 吉藤　康太, 岡田　啓吾, 梅澤　佳央, 坂下　千瑞子, 長尾　俊景, 山本　正英, 森　毅彦. Tisagenlecleucel治療後早期の ウイルス感染症モニタリング. 第45回　日本造血・免疫細胞療法学会総会 2023.02.11 名古屋

高橋　周平，千葉　桃子，田中　圭祐，梅澤　佳央，森　毅彦，山本　正英. Tisagenlecleucel投与後に発症した重症サイトカイン放出症候群に伴うcapillary leak syndrome. 第681回日本内科学会関東地方会 2022.10.22

梅澤　佳央,藤原 熙基,厚井 聡志,坂東 夏菜,齊藤 真貴子,長田 有生,吉藤 康太 ,田中 圭祐,岡田 啓五, 野上　彩子, 坂下 千瑞子,山本 正英,森 毅彦. 同種造血幹細胞移植後のBK polyomavirus血症の解析. 第84回日本血液学会学術集会 2022.10.15 福岡

齊藤　真貴子, 厚井　聡志, 坂東　夏菜, 藤原　熙基, 長田　有生, 吉藤　康太, 田中　圭祐, 岡田　啓五, 野上　彩子, 梅澤　佳央, 長尾　俊景, 坂下　千瑞子, 山本　正英, 東田　修二, 森　毅彦. 血液疾患患者における Clostridioides difficile 感染症についての検討. 第84回　日本血液学会学術集会 2022.10.15 福岡国際会議場

八木 真梨絵，田中 圭祐，吉藤 康太，岡田 啓五，梅澤 佳央，長尾 俊景，森 毅彦，山本 正英. 好酸球増多を伴うFIP1L1/PDGFRA陽性骨髄増殖性腫瘍におけるイマチニブの中止. 第84回　日本血液学会学術集会 2022.10.14 福岡

上村 悠，山本 正英，石村 匡崇，金兼 弘和，澤田 明久，平川 晃弘，今留 謙一，吉森 真由美，清水 則夫，小池 竜司，新井 文子. 慢性活動性EBウイルス感染症を対象としたJAK1/2阻害薬ルキソリチニブ第II相試験. 日本血液学会学術集会 2022.10.14

耕納　飛鳥、田中　圭祐、厚井　聡志、大内　史彦、梅澤　佳央、長尾　俊景、森　毅彦、豊田　茂雄、山本　正英. Alectinibで完全奏功達成後に同種移植を施行できたbrentuximab vedotin耐性ALK陽性未分化大細胞リンパ腫. 第62回日本リンパ網内系学会学術集会・総会 2022.06.24 川越

坂口　由季,中西　桃子,釼持　郁,足達　淑子,樺沢　勇司,荒川　真一,石塚　潤子,梅澤　佳央,山本　正英,森　毅彦,荒川　真一. 同種造血幹細胞移植患者の歯科衛生士による周術期口腔健康管理に関する検討. 日本がん口腔支持療法学会 2021.12.04 オンライン会議

田中 圭祐，山本 正英，高畑 篤，厚井 聡志，大内 史彦，中牧 尚子，中村 直哉，豊田 茂雄. 未治療原発性マクログロブリン血症に対する初期治療の検討. 第83回日本血液学会学術集会 2021.09.23

高畑 篤，田中 圭祐，梅澤 佳央，長尾 俊景，豊田 茂雄，山本 正英. 初発未治療濾胞性リンパ腫へのリツキシマブ/オビヌツズマブ併用ベンダムスチン療法に関する後方視的検討. 第83回日本血液学会学術集会 2021.09.23

梅澤 佳央, 本村 鷹多朗, 岡田 啓五, 野上 彩子, 長尾 俊景, 川又 紀彦, 東田 修二, 三浦 修, 山本 正英. 移植後letermovir予防群と非予防群における単一施設での網羅的ウイルスモニタリング. 第82回日本血液学会学術集会 2020.10.10

田中 圭祐, 山本 正英, 厚井 聡志, 久保木 麻衣, 大内 史彦, 中村 直哉, 豊田 茂雄. DLCBL患者における大量methotrexateによる中枢神経系再発予防について. 第82回日本血液学会学術集会 2020.10.10

本村 鷹多朗, 岡田 啓五, 野上 彩子, 梅澤 佳央, 長尾 俊景, 東田 修二, 立石 宇貴秀, 山本 正英. 形質細胞性腫瘍における18F-FDG PET/CT. 第82回日本血液学会学術集会 2020.10.10

山本 正英，佐藤 真穂，大西 康，松岡 賢市，鬼塚 真仁，渡邉 健一郎，菊田 敦，坂下 千端子，小林 徹，一戸 辰夫，福田 隆浩，井上 雅美，熱田 由子，新井 文子. 慢性活動性EBV感染症に対する同種移植. 第82回日本血液学会学術集会 2020.10

藤原 熙基, 野口 侑真, 長尾 俊景, 髙橋 幸伸, 新井 康祐, 濱村 貴史, 山下 知子, 野上 彩子, 梅澤 佳央, 渡邉 健, 坂下千瑞子, 山本 正英, 新井 文子, 川又 紀彦 , 東田 修二, 三浦 修. シタラビン・プレドニゾロン併用療法が奏功した多臓器型Langerhans細胞組織球症. 第 10 回日本血液学会関東甲信越地方会 2019.03.23 東京

梅澤 佳央, 渡邉 健, 長尾 俊景, 坂下 千瑞子, 野上 彩子, 川又 紀彦, 三浦 修, 山本 正英. 当院におけるCMLに対する1st line チロシンキナーゼ阻害薬によるDMR達成の検討. 第80回日本血液学会学術集会 2018.10.12 大阪

押川 学, 梅澤 佳央, 五十嵐 愛子, 垣花 和彦, 大橋 一輝, 川又 紀彦, 三浦 修, 山本 正英. 急性骨髄性白血病に対するアザシチジン治療の有効性. 第80回日本血液学会学術集会 2018.10.12 大阪

青山　慧,堤　大樹,齊藤　達也,山本　正英,渡邉　健,長尾　俊景,福田　哲也,川又　紀彦,三浦　修. FLU/BU4/TBIを用いた前処置による骨髄系腫瘍に対する同種移植成績. 第40回日本造血細胞移植学会総会 2018.02.02 札幌

Takashi Ikeda, Keita Mori, Koji Kawamura, Takehiko Mori, Shotaro Hagiwara, Yasunori Ueda, Kaoru Kahata, Naoyuki Uchida, Nobuhiro Tsukada, Satoshi Murakami, Masahide Yamamoto, Tsutomu Takahashi, Tatsuo Ichinohe, Makoto Onizuka, Yoshiko Atsuta, Yoshinobu Kanda, Shinichiro Okamoto, Kazutaka Sumani. Allogenic SCT for multiple myeloma relapsing or progressing after prior autologous SCT: JSHCT MM-WG. The 79th Annual Meeting of the Japanese Society of Hematology 2017.10.22 Tokyo, Japan

Tetsuya Saito, Hiroki Tsutsumi, Tomoko Yamashita, Hiroki Akiyama, Yoshihiro Umezawa, Ken Watanabe, Tetsuya Fukuda, Norihiko Kawamata, Osamu Miura, Masahide Yamamoto. Viral monitoring using multiplex PCR in patients with bone marrow failure treated with rabbit ATG. The 79th Annual Meeting of the Japanese Society of Hematology 2017.10.20 Tokyo

Kota Yoshifuji, Tetsuya Saito, Tomoko Yamashita, Ayako Nogami, Ken Watanabe, Tetsuya Fukuda, Norihiko Kawamata, Osamu Miura, Masahide Yamamoto. Clinical features and treatment outcome of methotrexate-associated Hodgkin lymphoma in our institute. The 79th Annual Meeting of the Japanese Society of Hematology 2017.10.20 Tokyo

山下　知子,水地　大輔,吉藤　康太,田中　圭祐,野上　彩子,渡邊　健,坂下　千瑞子,福田　哲也,新井 文子,川又　紀彦,三浦　修,山本　正英. 中枢神経リンパ腫に対するbusulfanを含む前処置を用いた自家末梢血幹細胞移植の検討. 第39回日本造血幹細胞移植学会総会 2017.03.03 松江

Daisuke Kudo, Takuya Komeno, Kazuteru Ohashi, Yuichi Nakamura, Atsushi Shinagawa, Takuya Suyama, Chikashi Yoshida, Takeshi Kobayashi, Naoki Wakimoto, Mitsuo Hori, Yosushi Okoshi, Takashi Kumagai, Atsushi Kato, Shigeo Toyoda, Koh Yamamoto, Masahide Yamamoto, Nobutaka Kawai, Akira Ohwada, Toru Miki, Hisashi Sakamaki, Hiroshi Kojima. Efficacy and Safety of CBD induction for ASCT-eligible NDMM - A phase 2 multicenter trial -. The 78th Annual Meeting of the Japanese Society of Hematology 2016.10.15 Yokohama

渡邉健,山本正英,内田慧美,鈴木さやか,三浦修,福田哲也. Two cases of Pneumocystis pneumonia during the treatment with brentuximab vedotin. 第78回日本血液学会学術集会 2016.10.14 パシフィコ横浜展示ホールA

Keisuke Tanaka, Sayaka Suzuki, Kota Yoshifuji, Ayako Nogami, Osamu Miura, Masahide Yamamoto. Clinical features and treatment outcome of therapy-related acute myeloid leukemia in our institute. The 78th Annual Meeting of the Japanese Society of Hematology 2016.10.14 Yokohama

Sayaka Suzuki, Keisuke Tanaka, Kohta Yoshifuji, Shihoko Suwa, Ken Watanabe, Osamu Miura, Michiko Kajiwara, Masahide Yamamoto. Correlation between PB and collected CD34+ cells in stem cell mobilization with chemotherapy + G-CSF. The 78th Annual Meeting of the Japanese Society of Hematology 2016.10.13 Yokohama

鈴木　さやか,田中　圭祐,迎　純一,渡邉　健,坂下　千瑞子,押川　学,山本　正英,福田　哲也,新井　文子,三浦　修. 染色体異常i(X)(p10)を伴う非定型慢性骨髄性白血病. 第4回日本血液学会関東甲信越地方会 2016.03.19 東京

迎　純一,鈴木　さやか,田中　圭祐,渡邉　健,坂下　千瑞子,押川　学,福田　哲也,新井　文子,三浦　修,山本　正英. 自家末梢血幹細胞移植（ASCT)後再発の多発性骨髄腫に対する2nd ASCTの有効性の検討. 第38回日本造血幹細胞移植学会総会 2016.03.05 名古屋

上野　絢子,迎　純一,渡邊　健,坂下　千瑞子,押川　学,山本　正英,福田　哲也,新井　文子,三浦　修. ベーチェット病に対するazathioprine治療に伴う治療関連急性骨髄性白血病の1例. 第621回日本内科学会関東地方会 2016.02 東京

Masahide Yamamto, Ken Watanabe, Gaku Oshikawa, Chizuko Sakashita, Tetsuya Fukuda, Arako Arai, Osamu Miura. A retrospective analysis of diffuse large B-cell lymphoma with multifocal skeleton involvement. The 77th Annual Meeting of the Japanese Society of Hematology 2015.10.16 Kanazawa

服部圭一郎,押川学,坂下千端子,山本正英,黒須哲也,福田哲也,新井文子,三浦修. R-CHOP療法後の再発・増悪DLBCLに対する自家造血幹細胞移植の後方視的解析. 第37回　日本造血細胞移植学会総会 2015.03.06 神戸

Akiyama H, Takase H, Kubo F, Miki T, Yamamoto M, Tomita M, Mochizuki M, Miura O, Arai A. Systemic MTX following intraviteal MTX administration prevents CNS infiltration of PIOL. 第76回日本血液学会学術集会 2014.10 大阪

Hattori K, Yamamoto M, Oshikawa G, Nagao T, Kurosu T, Fukuda T, Arai A, Miura O. A retrospective analysis of the efficacy of interim PET/CT in diffulse large B-cell lymphoma. 第76回日本血液学会学術集会 2014.10 大阪

Uchida E, Oshikawa G, Nagao T, Yamamoto M, Kurosu T, Fukuda T, Arai A, Miura O. A retrospective analysis of primary CNS lymphoma treated by short term MTX with WBRT. 第76回日本血液学会学術集会 2014.10 大阪

Ishida S, Akiyama H, Nagao T, Yamamoto M, Kurosu T, Fukuda T, Arai A, Miura O. Pulmonary mucormycosis after allo-SCT cured by long-term liposomal amphotericin B and lobectomy. 第76回日本血液学会学術集会 2014.10 大阪

秋山弘樹,坂下千端子,梅澤佳央,山本正英,黒須哲也,三浦修. イリノテカンを含む放射線化学療法後に発症したCBFB-MYH11を伴う治療関連急性骨髄性白血病. 日本血液学会　第1回関東甲信越地方会 2014.04.26 川越

内田慧美,長尾俊景,山本正英,黒須哲也,福田哲也,新井文子,三浦修. 当科におけるPh+ALLに対する同種造血幹細胞移植成績. 第36回日本造血幹細胞移植学会総会 2014.03.08 沖縄

望月晶史,　内田慧美,　渡邊健,　山本正英,　葛井総太郎,　尾崎司,　惣宇利正善,　小山高敏,　一瀬白帝,　三浦修. 広範な筋肉内及び皮下出血を契機に診断された後天性第13因子欠乏症. 第604回内科学会関東地方会例会 2014.03.08 東京

大谷悠祐,内田慧美,服部圭一郎,秋山弘樹,長尾俊景,山本正英,福田哲也,新井文子,三浦修. HLA1座不一致移植における低用量ATGの有効性についての後方視的検討. 第36回日本造血幹細胞移植学会総会 2014.03.08 沖縄